Clinician's Roundtable

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Samuel Muench, MD With colorectal cancer screening rates still falling short of national goals, new strategies are gaining attention—particularly blood-based tests. A recent modeling study compared this emerging tool to other options like stool-based testing and colonoscopy, exploring its potential as a colorectal cancer screening method and barriers to its adoption. Joining Dr. Charles Turck to break down the study and discuss the role of blood-based screening tests in shaping the colorectal cancer screening landscape is Dr. Samuel Muench. Dr. Muench is a board-certified and fellowship-trained gastroenterologist at Capital Digestive Care in Washington, DC.